1. Introduction {#sec0005}
===============

The numbers of alpacas (*Vicugna pacos*) and llamas (*Lama glama*) housed as companion animals is substantially increasing ([@bib0175]). Similarly, dromedaries (*Camelus dromedarius*) represent an important livestock species in both Africa and Asia and especially on the Arabian Peninsula, where they serve as a major source of milk and meat ([@bib0045]).

In 2012 a single-stranded, positive-sensed beta-coronavirus was isolated in the Kingdom of Saudi Arabia ([@bib0050], [@bib0280], [@bib0250]). Until today *Middle East respiratory syndrome coronavirus (MERS-CoV)* spread to 27 countries and caused more than 1,800 laboratory-confirmed cases of pneumonia including 643 fatal progressions in man (World Health Organization (2016) *Middle East respiratory syndrome coronavirus. Available at* [www.who.int/emergencies/mers-cov/en/](http://www.who.int/emergencies/mers-cov/en/){#intr0005} *. Accessed October 06, 2016).* Recent studies indicate that dromedaries appear to play a pivotal epidemiological role in transmitting the virus to humans, and experimental studies with dromedaries illustrate shedding of *MERS-CoV* after intranasal inoculation ([@bib0020], [@bib0095], [@bib0170]). However, there is a high demand for additional animal models, including the use of llamas and alpacas, which allow sophisticated pathological investigations in order to determine details of pathogenesis, cell tropism, and viral transmission of MERS-CoV. Besides MERS-CoV infections, dromedaries and Bactrian camels (*Camelus ferus*) also play a significant epidemiological role in other emerging infectious diseases such as West Nile Virus encephalitis ([@bib0120]), Hepatitis E Virus infections ([@bib0155]), and rabies ([@bib0075], [@bib0135]), demonstrating that naturally occurring and experimentally induced diseases in old and new world camelids might emerge as important animal models for studies upon the pathogenesis of such zoonotic infections.

The use of commercially available mono (mc)- and polyclonal (pc) antibodies in immunohistochemistry (IHC) has substantially improved our knowledge about the immunopathogenesis of pathological processes in a broad range of species and diseases ([@bib0065]). Primary antibodies detecting specific human and murine antigens can often be used successfully for the detection of conserved epitopes on tissues of various animals, including both domestic and exotic wild life species ([@bib0070], [@bib0100], [@bib0190], [@bib0195]).

Earlier studies have tested a limited panel of antibodies, mainly for the detection of lymphocytes, and were carried out on frozen tissue in only one camelid species (dromedary; [@bib0255], [@bib0260], [@bib0270]). In another study, one B cell marker (Pax-5) and one T cell marker (CD3) were used on paraffin embedded gut associated lymphoid tissue (GALT) of alpacas, experimentally infected with bovine viral diarrhea virus ([@bib0215]). However, the establishment of a broader panel of immunohistochemical markers on formalin fixed paraffin embedded (FFPE) tissue represents a prerequisite to elucidate the role of the immune response in diseases of camelids. Therefore, it was the aim of the present study to test the applicability of commercially available immunohistochemical markers for the detection of immune cells in new- and old-world camelids in FFPE tissue of different lymphoid organs to provide a solid fundament for further research on healthy and diseased camelids with special respect to prospective spill-over infections.

2. Materials and methods {#sec0010}
========================

2.1. Animals and tissue samples {#sec0015}
-------------------------------

Tissues used in the present study were taken from the archive of the Department of Pathology, University of Veterinary Medicine Hannover. A complete necropsy was performed and sampled organs were fixed in 10% non-neutral buffered formalin for 24 h and routinely embedded for histology. The archive was screened for cases of new- and old world camelids, in which lymphoid organs were available. Briefly, formalin fixed tissues were automatically dehydrated by an ascending alcohol series using the embedding machine Thermo Scientific™ Shandon™ Pathcentre™ (Thermo Fisher Scientific, Langenselbold, Germany) and subsequently embedded in paraffin. 4 μm thick paraffin sections of lymphoid organs were stained with H&E and examined by routine light microscopy. Lymphoid tissues affected by destruction of organotypic architecture and/or major lesions such as severe suppurative inflammation, abscess or granuloma formation, and neoplastic processes were excluded from the present study. Moreover, lymphoid organs with severe lymphoid depletion and marked auto- and heterolytic changes were omitted from further processing. Overall, the lowest number of lymphoid organs fulfilling the inclusion criteria was available from dromedaries. In particular, 5 spleens, 5 mesenteric lymph nodes, and 5 tracheobronchial lymph nodes of dromedary origin were obtainable. The number of lymphoid tissues from the remaining species (Bactrian camels, llamas, and alpacas) was consequently adjusted to n = 5 for each of the aforementioned organs. Accordingly, in total 20 spleens and 20 tracheobronchial and 20 mesenteric lymph nodes were investigated in the present study (5 per species for each organ). Additionally, thymus tissue was available from two young animals of each species (8 animals with a median age of 3 days).

2.2. Immunohistochemistry {#sec0020}
-------------------------

For IHC a panel of different antibodies (n = 14) was applied on lymph nodes of each species to screen for their general suitability for camelid lymphoid tissue ([Table 1](#tbl0005){ref-type="table"} ). The tested antibodies have previously been reported to cross-react with canine and bovine immune cells, respectively ([@bib0015], [@bib0025], [@bib0080], [@bib0130], [@bib0140], [@bib0150], [@bib0180], [@bib0210], [@bib0245]). Consequently, archived FFPE sections from mesenteric lymph nodes of a dog or an ox were used as positive controls. IHC was performed by use of the avidin-biotin-peroxidase complex method as described previously ([@bib0025]). Briefly, after dewaxing by incubating the sections for 5 min twice in Roticlear^®^ (Roth C. GmbH & Co. KG, Karlsruhe, Germany) and rehydration in isopropanol and ethanol (96%; each for 5 min), endogenous peroxidase activity was blocked by incubation of sections in 85% ethanol with 0.5% H~2~O~2~ for 30 min at room temperature (RT). If necessary ([Table 1](#tbl0005){ref-type="table"}), pretreatment was either done by incubating the sections in citrate buffer (2.1 g citric acid monohydrate in 1 l distilled water, adjusted with NaOH to pH = 6.0) for 20 min in a microwave (800 W) or with 20 min pronase treatment at 37 °C (pronase E, 50 mg in 100 ml phosphate buffered saline \[PBS\] and 0.1 g CaCl~2~  × 2H~2~O with pH adjusted to 7.2). Subsequently, sections were transferred to Shandon Coverplates™ (Thermo Electron GmbH, Dreieich, Germany). To block unspecific binding, inactivated normal rabbit serum (for CD208 and Foxp3) or normal goat serum (all other antibodies) was applied for 30 min in a dilution of 1:5 with PBS (pH 7.2). For appropriate negative controls, primary antibodies ([Table 1](#tbl0005){ref-type="table"}) were replaced by ascites fluid from Balb/c mice (1:1000; CD79α, Pax-5, MUM1 protein, HLA-DR antigen, CD68, myeloid/histiocyte antigen, CD204, CD205), rabbit (1:3000; CD3, CD20, Iba-1, lysozyme), and rat serum (1:1000; Foxp3, CD208), respectively. After 90 min of incubation at RT and subsequent washing with PBS, the appropriate secondary biotinylated antibody was added in a dilution of 1:200 with PBS. Incubation for 60 min at RT was followed by treatment with the avidin-biotin-peroxidase complex (Vectastain ABC Kit Standard, Vector Laboratories, Burlingame, California, USA) according to the manufacturer's protocol. Visualization of the reaction was achieved by the chromogen 3,3-diaminobenzidine tetrahydrochloride (DAB, 0.05%, Sigma Aldrich Chemie GmbH, Taufkirchen, Germany) with addition of 0.03% H~2~O~2~. Slides were finally slightly counterstained with Mayer's hematoxylin (Roth C. GmbH & Co KG, Karlsruhe, Germany).Table 1Antigen, clonality, species, source, dilution, antigen retrieval and secondary antibodies used for IHC.Table 1antigenclonality, clone, speciessourcedilutionantigen retrievalsecondary Abresult**CD3**pc, rabbitDakoCytomation1:500CitratGAR+**CD79α**mc, HM57, mouseAbcam1:5000CitratGAM(+)**CD20**pc, rabbitThermo Fisher scientific1:200CitratGAR+**Pax-5**mc, 24/Pax-5, mouseBD Biosciences1:10\#GAM--**Mum1**mc, MUM1p, mouseDakoCytomation1:10\#GAM--**Foxp3**mc, FJK-16s, rateBioscience1:10\#RAR--**HLA-DR**mc, TAL.1B5, mouseDakoCytomation1:100CitratGAM+**Iba-1**pc, rabbitWako1:500CitratGAR+**CD68**mc, KP1, mouseDakoCytomation1:100CitratGAM+**Myeloid/histiocyte**\
**antigen**mc, MAC387, mouseDakoCytomation1:500CitratGAM+**CD204**mc, SRA-E5, mouseTransgenic Inc.1:1000CitratGAM+**CD205**mc, CC98, mouseAbD Serotec1:10\#GAM--**CD208**mc, 1010E1.01, ratDendritics1:200CitratRAR+**Lysozyme**pc, rabbitDako1:10\#GAR--[^1]

2.3. Evaluation and quantification {#sec0025}
----------------------------------

Sections were viewed under an Olympus BX-51 digital camera microscope (Olympus Optical Co., Hamburg, Germany). Positive immunoreactivity was appreciated if cellular staining pattern and cellular morphology fitted with the expected distribution pattern and immunoreactivity appearance of the positive control. All antibodies, which produced positive results on camelid lymph nodes, were applied to serial sections of lymph node, spleen, and thymus of all examined camelid species and comparatively assessed according to a semiquantitative scoring system ([@bib0100]). For all camelid species, scoring was adapted to the anatomical compartments of dromedary lymph nodes, which are known to differ from other mammals in some aspects ([@bib0010], [@bib0265], [@bib0255], [@bib0260]). Within sections of spleens, positive immunoreactivity was differentially evaluated for the periarteriolar lymphoid sheaths (PALS), follicles, sinuses, and splenic cords. In a similar manner, immunopositivity was determined for lymphoid nodules (LN), dense anodular lymphoid tissue (DALT), and diffuse lymphoid tissue (DLT) of lymph nodes, and medulla and cortex of thymus according to the following score: 0 = no positive staining cells; 1 = \< 10%; 2 = 10--50%; 3 = 51--90%; 4 = \>90% immunolabeled cells.

3. Results and discussion {#sec0030}
=========================

3.1. Histopathology {#sec0035}
-------------------

Even though lymphoid organs with significant lesions were avoided in the present study, intestinal diseases and associated lesions in tributary lymph nodes of camels are rather common ([@bib0035], [@bib0115], [@bib0225]). Consequently, evaluation of H&E staining of lymphoid tissues by light microscopy revealed minor lesions in the majority of the investigated lymphoid organs. These lesions included mild to moderate degrees of extramedullary hematopoiesis, hyperemia, hemosiderosis, sinus histiocytosis, plasmocytosis, focal fibrosis, edema, multifocal hemorrhages, and mild neutrophilic and eosinophilic infiltrations.

3.2. Immunohistochemistry {#sec0040}
-------------------------

In the present study, six out of ten mc antibodies and three out of four pc antibodies were demonstrated to be suitable for detection of different antigens, based on an expected immunoreactivity distribution pattern and cellular morphology in lymphoid tissues of camelids. Immunohistochemistry was only judged specific if cellular staining characteristics fitted the pattern in canine and bovine control tissue (Supplemental [Fig. S1](#upi0005){ref-type="supplementary-material"}) and if negative controls of camelid tissue (Supplemental [Fig. S2](#upi0010){ref-type="supplementary-material"}) lacked immunoreactivity. Averages and standard deviations of the semiquantitative scores for all nine antigens are summarized in [Table 2](#tbl0010){ref-type="table"}, [Table 3](#tbl0015){ref-type="table"} with respect to different compartments of spleen and lymph node tissues, respectively. Four mc antibodies for the detection of Pax-5- (B cells), MUM1- (plasma cells, certain B cells), Foxp3- (regulatory T cells), and CD205-antigen (dendritic cells (DCs), certain B and T cells) and one pc antibody for identification of lysozyme (macrophages) showed specific reaction patterns on canine and bovine positive controls, respectively, but lacked specific immunopositivity on FFPE sections of camelid organs in all tested dilutions (Supplemental [Fig. S3](#upi0015){ref-type="supplementary-material"}) without and with both tested pretreatments (heat retrieval and pronase treatment, respectively). Contrary to the present investigation, Pax-5 has been reported to react on GALT of alpacas ([@bib0215]); however, it remains unclear if a similar or a differing antibody has been used in the former study or whether the contrasting results are attributed to variations in the protocols used. No major differences were determined between different camelid species concerning the cellular staining patterns and the general distribution of immunolabeled cells for all investigated antibodies ([Table 2](#tbl0010){ref-type="table"}, [Table 3](#tbl0015){ref-type="table"}). Thus, the results implicate a relatively similar anatomical architecture of lymphoid organs of different camelid species, even if detailed anatomical descriptions of these organs for llamas, alpacas and Bactrian camels are not available. Moreover, no considerable differences were discovered between tracheobronchial and mesenteric lymph nodes in any species.Fig. S1Demonstration of the immunohistochemical reaction pattern of the tested antibodies on canine and bovine control tissue. Shown are the reactions of antibodies that also produced specific and similar immunoreactivity on camelid tissue. (A) CD20; lymph node, dog. Compare to Fig. 1D. (B) CD79α; lymph node, dog. Compare to Fig. 1H. (C) CD3; lymph node, dog. Compare to 2D. (D) HLA-DR; lymph node, dog. Compare to 2H. (E) Iba1; lymph node, dog. Compare to 3D. (F) CD204; lymph node, dog. Compare to 3H. (G) Myeloid/histiocyte antigen; lymph node, dog. Compare to Fig. 4D. (H) CD68; lymph node; dog. Compare to Fig. 4H. (I) CD208; lymph node, bovine. Compare to Fig. 5D. Scale bar in A--I = 20 μm.. Fig. S2Demonstration of representative negative controls (camelid lymphoid tissue) for immunohistochemistry. For negative controls, the respective primary antibody was replaced by ascites fluid from Balb/c mice (A; 1:1000; negative control for CD79α, Pax-5, MUM1 protein, HLA-DR antigen, CD68, myeloid/histiocyte antigen, CD204, CD205), rabbit serum (B; 1:3000; negative control for CD3, CD20, Iba-1, lysozyme), and rat serum (C; 1:1000; negative control for Foxp3, CD208), respectively. Scale bar in A--C = 20 μm. Fig. S3Immunohistochemistry for the detection of immune cells in camelid tissue, illustrating the antibodies that worked in positive control tissue, but lacked specific immunoreactivity on camelid lymphoid tissue in all tested dilutions without and with different pretreatments (heat retrieval, pronase treatment). (A) Pax 5; lymph node, dog. Strong nuclear immunoreactivity of Pax-5 in the B cell compartment of a canine lymph node. (B) Pax-5; lymph node, Bactrian camel. Absent specific immunoreaction for Pax-5. (C) MUM1; lymph node, dog. Scattered immunpositive cells with nuclear signal in a lymph node of a dog. (D) MUM1; lymph node, Bactrian camel. In contrast to canine control tissue, MUM1 lacks specific immunoreaction on camelid tissue. (E) Foxp3; lymph node, dog. Nuclear signal in regulatory T cells in a canine lymph node. (F) Foxp3; lymph node, Bactrian camel. Absent immunoreactivity for the tested antibody. (G) CD205; lymph node, bovine. Scattered immunoreactive cells, suggestive of dendritic cells in a bovine lymph node. (H) CD205; lymph node, Bactrian camel. Absent immunosignal for CD205 on camelid lymphoid tissue. (I) Lysozyme; lymph node; dog. Immunpositive cells with cytoplasmic signal in cells with macrophage morphology within the sinus of a canine lymph node. (J) Lysozyme; lymph node, Bactrian camel. Absent immunoreactivity for lysozyme in a camelid lymph node. Scale bar in A--J = 20 μm. Table 2Distribution of antigens in different compartments of spleen.Table 2Detected antigenFolliclesPALSRed Pulp CordsRed pulp SinusesLADCLADCLADCLADC**CD3**1.001.000.661.003.003.002.603.001.601.801.601.601.001.001.201.400.000.000.470.000.000.000.490.000.490.400.490.490.000.000.750.49  **CD20**3.003.003.003.201.601.801.201.001.801.801.001.602.001.400.801.000.630.000.710.750.490.400.400.000.400.400.630.490.630.800.400.00  **CD79**1.802.001.250.251.200.800.400.501.602.001.001.001.000.200.000.000.400.000.830.430.400.750.490.500.490.000.630.000.890.400.000.00  **Iba-1**1.201.001.001.003.001.802.202.602.002.001.802.001.001.200.601.200.400.000.000.000.000.400.750.800.000.000.400.000.630.400.490.75  **CD204**0.601.001.000.801.201.001.400.801.601.801.601.800.601.000.800.600.490.000.000.400.400.630.490.400.490.400.490.400.490.890.400.49  **m/h antigen**0.800.671.001.001.001.001.401.002.001.801.801.201.200.600.800.800.400.470.000.000.630.000.490.000.000.400.400.400.400.800.400.75  **HLA-DR**2.201.672.001.802.002.601.802.801.801.201.401.800.200.000.400.000.750.941.000.980.000.490.400.400.400.400.490.400.400.000.490.00  **CD208**0.000.000.000.000.200.000.000.000.400.200.400.400.400.200.000.000.000.000.000.000.400.000.000.000.490.400.490.490.490.400.000.00  **CD68**0.000.000.000.200.600.000.000.600.800.800.600.800.200.000.000.000.000.000.000.400.490.000.000.490.400.400.490.400.400.000.000.00[^2]Table 3Distribution of antigens in different compartments of lymph nodes.Table 3Detected antigenLymphoid nodulesDense anodular lymphoid tissueDiffuse lymphoid tissueLLAADDCCLLAADDCCLLAADDCC**CD3**1.001.001.001.001.201.201.251.202.803.002.802.602.802.603.003.001.200.801.001.401.000.801.001.000.000.000.000.000.400.750.430.400.400.000.400.490.400.490.000.000.400.400.000.490.630.400.000.00  **CD20**3.203.002.802.753.003.003.402.801.601.602.001.601.601.401.601.602.001.201.801.800.801.202.401.400.400.000.400.430.000.630.490.750.490.800.630.800.490.490.490.490.630.400.980.400.400.400.490.49  **CD79**2.802.751.001.801.501.401.801.602.001.801.602.001.251.201.201.202.201.800.401.001.250.801.000.600.400.430.630.400.871.020.981.360.000.400.490.000.430.400.400.750.750.400.490.890.430.400.630.49  **Iba-1**1.601.751.001.201.001.201.201.202.001.601.401.801.201.801.601.603.002.402.002.402.202.002.002.800.490.430.630.400.000.400.400.400.000.490.800.400.400.400.490.490.000.490.630.490.750.630.630.40  **CD204**1.001.251.001.000.800.601.000.601.401.401.201.201.200.801.001.202.201.802.002.402.202.001.602.000.000.430.000.630.400.490.000.490.490.800.400.400.400.400.000.400.400.400.000.490.750.630.490.00  **m/h antigen**1.200.750.800.400.800.601.000.801.000.800.800.600.801.001.401.001.801.601.201.401.401.401.401.800.400.430.400.490.400.490.000.400.000.400.400.490.400.000.800.000.400.490.400.490.800.490.490.75  **HLA-DR**2.602.752.602.202.402.602.203.002.201.602.002.001.601.801.801.801.602.002.002.201.601.602.201.400.490.430.800.980.800.800.750.000.400.490.000.000.490.400.400.400.490.630.630.400.490.490.400.49  **CD208**0.200.000.000.000.000.000.000.000.600.800.200.400.400.000.200.201.000.200.400.400.600.600.400.600.400.000.000.000.000.000.000.000.490.400.400.490.490.000.400.400.000.400.800.490.490.490.490.49  **CD68**0.200.000.000.000.000.000.200.200.600.600.200.400.200.200.600.400.800.800.000.000.200.200.600.400.400.000.000.000.000.000.400.400.490.490.400.490.400.400.490.490.400.400.000.000.400.400.490.49[^3]

3.3. B cells {#sec0045}
------------

Two out of three different antibodies appeared suitable to label cells of the B cell lineage ([Table 1](#tbl0005){ref-type="table"}). In spleen, CD20 immunoreactive cells were mainly located in small follicles adjacent to the PALS (Malpighian corpuscles, [Fig. 1](#fig0005){ref-type="fig"} A). Similarly, tracheobronchial and mesenteric lymph nodes showed positive immunostaining within LN and adjacent areas of DALT and DLT ([Fig. 1](#fig0005){ref-type="fig"}B). Scattered immunoreactive cells were additionally present in all other investigated compartments of spleen and lymph nodes. In thymus, CD20-positive cells were mainly located in the medulla (score ½; [Fig. 1](#fig0005){ref-type="fig"}C). Single positive cells were additionally detected multifocally within the cortex. CD20 immunoreactive cells showed a distinct membrane-bound immunopositivity and were characterized by small size, round shape, scant amounts of cytoplasm and a centrally located round nucleus resembling mature B cells. Additionally, larger cells with similar morphology but a higher amount of cytoplasm were detected within germinal centers, thus most likely representing immunoblasts ([Fig. 1](#fig0005){ref-type="fig"}D). These observations are in consistence with findings of previous studies on frozen dromedary tissue, which described relatively similar localization of the B cell specific antigens CD21 and CD22 ([@bib0255], [@bib0260], [@bib0270]). In humans, CD20 is mainly expressed by pre- and mature B cells; however, some human T cell subsets have also been reported to be immunoreactive for CD20 ([@bib0110]). Interestingly, the present results suggest that a similar expression pattern might exist in camelids, as CD20 was expressed by some lymphocytes within the DALT, which resembles the T cell compartment of camelid lymph nodes ([@bib0010], [@bib0260]). The distribution and amount of CD20 positive cells in camelid thymus are in line with investigations on human thymus, which detected similar numbers of B cells in the medulla of children ([@bib0205]). B cells have been reported to present autoantigens as an important step in the negative selection of T lymphocytes and induction of T cell tolerance ([@bib0185]).Fig. 1Representative immunohistochemical reactions for detection of B cell populations in the spleen, lymph node, and thymus of a Bactrian camel (A-D: CD20; E-H: CD79α). Avidin-biotin-peroxidase complex method with 3,3′-diaminobenzidine as chromogen. (A) CD20; spleen. CD20 positive cells with distinct membrane-bound signal and lymphoid morphology, suspicious of B cells, are mainly located in Malpighian corpuscles (MC) adjacent to the periarteriolar lymphoid sheath (PALS), while only scattered immunopositive cells are seen throughout the red pulp (RP). Scale bar = 100 μm. (B) CD20; lymph node. CD20 positive cells are not only located in lymphoid nodules (LN), which resemble the B cell compartment, but there are also low numbers of cells with lymphoid morphology positioned within dense anodular lymphoid tissue (DALT; T cell compartment) and diffuse lymphoid tissue (DLT). Scale bar = 100 μm. (C) CD20; thymus. Scattered CD20 immunopositive cells are noted within the thymic medulla (M), while there is no immunoreaction within the thymic cortex (C). Scale bar = 100 μm. (D) CD20; lymph node. Higher magnification of the inset in (B). Morphologically, CD20 immunopositive cells are characterized by lymphocyte morphology and an intense membrane-bound signal. Most cells have relatively low amount of cytoplasm, suggestive of mature B cells. However, there are scattered cells with a relatively larger morphology, suggestive of immunoblasts. Scale bar = 20 μm. (E) CD79α; spleen. Compared to CD20 (A) only few scattered cells, immunopositive for CD79α are seen within the MC, PALS, and RP of the spleen, while there is a relatively intense background staining and diffuse immunopositivity in blood vessel walls (arrow). Scale bar = 100 μm. (F) CD79α; lymph node. CD79α antigen is mainly expressed in LN of lymph nodes. Moderate numbers of scattered immunopositive cells are also found throughout the DLT, while there are only rarely CD79α positive cells within the DALT. Similar to spleen, blood vessel walls stain also positive (arrows). Scale bar = 100 μm. (G) CD79α; thymus. Few cells, predominantly located within the thymus medulla stain positive for CD79α antigen. Scale bar = 100 μm. (H) CD79α; lymph node. Higher magnification of the inset in (F). Morphologically, CD79α immunopositive cells are characterized by lymphocyte morphology with a cytoplasmic immunoreaction pattern. However, few cells show a nuclear staining pattern, which is considered a false positive reaction (arrowheads). Scale bar = 20 μm.Fig. 1

Similarly to CD20, CD79α labeled cells were predominantly located in splenic follicles ([Fig. 1](#fig0005){ref-type="fig"}E), LN ([Fig. 1](#fig0005){ref-type="fig"}F), and thymic medulla ([Fig. 1](#fig0005){ref-type="fig"}G). However, scattered positive cells were inconsistently present in all other compartments, including DLT of lymph nodes ([Fig. 1](#fig0005){ref-type="fig"}F), and distinct staining was rare in splenic follicles, which however stained positive for CD20 ([Fig. 1](#fig0005){ref-type="fig"}A). Overall, the CD79α labeled cell population was considerably smaller compared to CD20, indicating that CD20 might label a broader population of the B cell lineage. Moreover, the anti-CD79α antibody produced pronounced unspecific background and a positive immunoreactivity of non-lymphoid cells including smooth muscle and endothelium as previously mentioned for porcine tissue ([@bib0055]; [Fig. 1](#fig0005){ref-type="fig"}E). A nuclear staining pattern for CD79α is known to represent an unspecific reaction in several species including dogs and cats ([@bib0160]), thus only a distinct cytoplasmic and membranous staining was judged as specific immunoreactivity ([Fig. 1](#fig0005){ref-type="fig"}H).

3.4. T cells {#sec0050}
------------

One out of two tested antibodies detected T cells in camelids ([Table 1](#tbl0005){ref-type="table"}). As previously reported for frozen sections of dromedaries ([@bib0260], [@bib0270]), CD3 positively staining cells were mainly located within the PALS of spleen ([Fig. 2](#fig0010){ref-type="fig"} A) and the DALT of lymph nodes ([Fig. 2](#fig0010){ref-type="fig"}B). The DALT of dromedaries resembles the T cell compartment and is comparable to the paracortex of other mammalian species ([@bib0010]). A minor population of CD3-immunoreactive cells was dispersed within cords and sinuses of the red pulp and single cells were detected in the splenic follicles as well as in LN and DLT of lymph nodes ([Fig. 2](#fig0010){ref-type="fig"}A and B). Additionally, abundant numbers of CD3-positive cells were present in the medulla and cortex of thymus as expected (score 3; [Fig. 2](#fig0010){ref-type="fig"}C). Whereas cortically located cells were closely packed, positive cells within the medulla were more loosely arranged and intermingled with immunonegative cells. In all locations, the pc anti-CD3 antibody displayed a distinct membrane-bound signal on cells with lymphoid morphology ([Fig. 2](#fig0010){ref-type="fig"}D). Similarly to CD20 and CD79α, commercially available anti-CD3 antibodies have been frequently used in other cross-reactivity studies and are known to be suitable for various species ([@bib0030], [@bib0055], [@bib0100], [@bib0235]).Fig. 2Representative immunohistochemical reactions for detection of T cells and antigen presenting cells in the spleen, lymph node, and thymus of a Bactrian camel (A-D: CD3; E-H: HLA-DR). Avidin-biotin-peroxidase complex method with 3,3′-diaminobenzidine as chromogen. (A) CD3; spleen. CD3 positive cells are predominantly seen throughout the periarteriolar lymphoid sheath (PALS), while only scattered immunopositive cells are seen throughout the red pulp (RP). Scale bar = 100 μm. (B) CD3; lymph node. Numerous cells stain positive for CD3 antigen within dense anodular lymphoid tissue (DALT), which resembles the T cell compartment of camelids. Moderate numbers of scattered immunpositive cells are also noted within diffuse lymphoid tissue (DLT). Scale bar = 100 μm. (C) CD3; thymus. Numerous CD3-positive cells are seen within the medulla (M) and cortex (C) of thymus. Scale bar = 100 μm. (D) CD3; lymph node. Higher magnification of the inset in (B). Morphologically, CD3 immunopositive cells are characterized by lymphocyte morphology with intense membrane-bound signal (arrow). Scale bar = 20 μm. (E) HLA-DR; spleen. Numerous HLA-DR positive cells are located throughout the splenic RP and are similarly found within the PALS. Scale bar = 100 μm. (F) HLA-DR, lymph node. Immunoreactive cells are seen predominantly seen within the DLT; however, moderate numbers of cells within the DALT are similarly immunoreactive. (G) HLA-DR, thymus. HLA-DR positive cells are mainly located within the thymus medulla. Fewer cells throughout, scattered throughout the cortex are also HLA-DR positive. Scale bar = 100 μm. (H) HLA-DR, lymph node. Higher magnification of the inset in (E). Morphologically, the anti-HLA-DR antibody labels cells with histiocyte-like morphology and produces an intense membranous and intracytoplasmic diffuse positive signal on medium sized to large cells with plenty cytoplasm and cytoplasmic extensions (arrowhead). In addition, cells with lymphocyte morphology and lower amounts of cytoplasm are similarly positive for HLA-DR (arrow). Scale bar = 20 μm.Fig. 2

3.5. Histiocytic cells {#sec0055}
----------------------

Six out of eight markers labeled subsets of camelid histiocytic cells ([Table 1](#tbl0005){ref-type="table"}). The histiocytic lineage includes an extensive range of phenotypes and a variety of heterogeneous subsets, thus requiring several markers for their identification ([@bib0165]). The morphology of labeled cells was relatively similar for all markers mentioned below. There was membranous and intracytoplasmic diffuse positivity on medium sized to large cells with plenty cytoplasm, kidney-shaped nuclei, and more or less distinct, cytoplasmic extensions. The most widespread immunoreaction pattern was observed by detection of HLA-DR (α chain). The anti-HLA-DR antibody labeled the cytoplasm of a large population of macrophage-like cells. Most of these cells were located in the splenic red pulp ([Fig. 2](#fig0010){ref-type="fig"}E), the DLT of lymph nodes ([Fig. 2](#fig0010){ref-type="fig"}F), and the medulla of thymus ([Fig. 2](#fig0010){ref-type="fig"}G). Additionally, moderate numbers of HLA-DR-positive cells were observed in T cell compartments of spleen and lymph nodes, germinal centers of splenic follicles, LN of lymph nodes, and the cortex of thymus ([Fig. 2](#fig0010){ref-type="fig"}E--G). Nonetheless, HLA-DR was also expressed by a cell population of moderate size with lymphoid morphology ([Fig. 2](#fig0010){ref-type="fig"}H) in splenic follicles, LN, PALS, DALT, and thymus (score 3). These findings are consistent with previously described distribution patterns of HLA-DR in humans ([@bib0060]), dogs ([@bib0240], [@bib0245]), and cattle ([@bib0180]). In contrast to some other macrophage markers mentioned below, HLA-DR antigen is also apparent on DCs, B cells, activated T cells, and certain endothelia and therefore seems relatively inappropriate for labelling of a specific histiocytic lineage ([@bib0060]). The results indicate that the same might be true for camelid tissue.

Overall, the applied antibodies against Iba-1 ([Fig. 3](#fig0015){ref-type="fig"} A--D), CD204 ([Fig. 3](#fig0015){ref-type="fig"}E--H), and myeloid/histiocyte antigen ([Fig. 4](#fig0020){ref-type="fig"} A--D) stained a relatively lower proportion of cells as compared to anti-HLA-DR specific IHC, thus probably indicating higher specificity. All three antibodies labeled macrophage-like cells in the splenic red pulp and DLT of lymph nodes. Fewer cells were localized in splenic follicles, LN and DALT. Surprisingly, Iba-1-specific IHC revealed an additional characteristic circular staining pattern, surrounding smaller blood vessels and central arteries of the splenic PALS of all camelid species ([Fig. 3](#fig0015){ref-type="fig"}A). In contrast to myeloid/histiocyte antigen and CD204, which were expressed to a low degree in medulla and cortex of thymus (score 1; Figs. [3](#fig0015){ref-type="fig"}G, [4](#fig0020){ref-type="fig"}C), Iba-1 antigen was expressed to a moderate degree (score 2) in both compartments ([Fig. 3](#fig0015){ref-type="fig"}C). According to the literature, Iba-1 is located on all cell types of the monocyte/macrophage lineage of mice ([@bib0125]) and dogs ([@bib0140]), and CD204 is known to be expressed by red pulp and sinus macrophages of several species ([@bib0230]). Myeloid/histiocyte antigen (synonym leucocyte antigen L1; calprotectin) is widely expressed by recently infiltrated, blood-borne monocytes/macrophages of humans, monkeys, dogs, and in bovine granulomas ([@bib0080], [@bib0145], [@bib0200], [@bib0210]). Moreover, myeloid/histiocyte antigen specific antibodies are also suitable for labelling of neutrophils in contrast to all previously mentioned markers ([@bib0040], [@bib0085]). In line with these investigations, some cells with neutrophilic morphology were similarly labeled in the tracheobronchial and mesenteric lymph nodes of llamas, dromedaries and Bactrian camels with mild neutrophilic infiltration (Supplemental [Fig. S4](#upi0020){ref-type="supplementary-material"}).Fig. S4Immunohistochemistry for myeloid/histiocyte antigen in a lymph node of a llama. Note immunopositive signal in cells, morphologically consistent with neutrophilic granulocytes (arrow). Scale bar = 20 μm. Fig. 3Representative immunohistochemical reactions for detection of histiocytic cells in the spleen, lymph node, and thymus of a Bactrian camel (A-D: Iba-1; E-H: CD204). Avidin-biotin-peroxidase complex method with 3,3′-diaminobenzidine as chromogen. (A) Iba-1; spleen. Iba-1-specific immunohistochemistry shows a characteristic perivascular staining pattern (arrow), which is not observed for any other marker. Several immunopositive cells are also noted scattered throughout the splenic red pulp (RP), and perivascularly within the periarteriolar lymphoid sheath (PALS). Scale bar = 100 μm. (B) Iba-1; lymph node. Numerous cells stain positive for Iba-1 antigen within diffuse lymphoid tissue (DLT), which resembles the T cell compartment of camelids. Moderate numbers of scattered immunpositive cells are also noted within dense anodular lymphoid tissue (DALT). Scale bar = 100 μm. (C) Iba-1; thymus. A moderate number staining intensely positive for Iba-1 antigen are seen within both compartments of the thymus, cortex (C) and medulla (M). Scale bar = 100 μm. (D) Iba-1; lymph node. Higher magnification of the inset in (B). Morphologically, Iba-1 immunopositive cells are characterized by histiocyte-like morphology with abundant intensely and diffusely labeled cytoplasm and many cells show pronounced cytoplasmic projections. Scale bar = 20 μm. (E) CD204; spleen. Similar to Iba-1 but with absent perivascular staining pattern, several immunpositive cells are noted throughout the splenic RP with few immunoreactive cells in the PALS. Scale bar = 100 μm. (F) CD204; lymph node. CD204 immunopositive cells are mainly found within the DLT, while only few scattered cells are positive within the DALT. Scale bar = 100 μm. (G) CD204, thymus. In contrast to Iba-1 (C), a relatively lower number of CD204 immunpositive cells is noted within thymus medulla and cortex. Scale bar = 100 μm. (H) CD204; lymph node. Higher magnification of the inset in (F). CD204 positive cells are characterized by relatively high amounts of diffusely stained cytoplasm, peripheral nuclei, and histiocyte-like morphology. Scale bar = 20 μm.Fig. 3Fig. 4Representative immunohistochemical reactions for detection of histiocytic cells in the spleen, lymph node, and thymus of a Bactrian camel (A-D: myeloid/histiocyte antigen; E-H: CD68). Avidin-biotin-peroxidase complex method with 3,3′-diaminobenzidine as chromogen. (A) Myeloid/histiocyte antigen; spleen. Several intensely immunopositive cells are observed scattered throughout the splenic red pulp (RP) and within the periarteriolar lymphoid sheath (PALS). Scale bar = 100 μm. (B) Myeloid/histiocyte antigen; lymph node. Positively labeled cells are mainly seen within diffuse lymphoid tissue (DLT) with fewer numbers of scattered immunpositive cells within dense anodular lymphoid tissue (DALT). Note the cluster of immunopositive cells within the sinus and DLT in the upper part of the figure. Scale bar = 100 μm. (C) Myeloid/histiocyte antigen; thymus. Scattered immunopositve cells are seen throughout the cortex (C) and medulla (M) of the thymus. Scale bar = 100 μm. (D) Myeloid/histiocyte antigen; lymph node. Higher magnification of the inset in (B). Morphologically, the cells reacting positive for myeloid/histiocyte antigen are characterized by histiocytic morphology, moderate size, round to oval cell bodies and abundant cytoplasm, which is intensely and diffusely positive. Some cells show discrete cellular processes. Scale bar = 20 μm. (E) CD68; spleen. Only very few individualized cells (arrows) within the splenic RP are immunoreactive for CD68, while there are no positive cells within the PALS. Scale bar = 100 μm. (F) CD68; lymph node. Similar to spleen, CD68 is only rarely expressed on very few cells within DLT and DALT. Scale bar = 100 μm. (G) CD68; thymus. No immunopositive cells are seen in the thymus cortex and medulla. Scale bar = 100 μm (H) CD68; lymph node. Higher magnification of the inset in (F). Morphologically, CD68 positive cells show histiocytic morphology with abundant diffusely to slightly granular positive cytoplasm and peripheral nuclei (arrowhead). Scale bar = 20 μm.Fig. 4

CD68-specific IHC stained the cytoplasm of only very few cells in spleen and lymph nodes of camels in the present study regardless of the species ([Fig. 4](#fig0020){ref-type="fig"}E-H). They were mainly located in splenic cords of the red pulp ([Fig. 4](#fig0020){ref-type="fig"}E), and DALT and DLT of lymph nodes ([Fig. 4](#fig0020){ref-type="fig"}F). CD68 was not expressed in thymus of any species ([Fig. 4](#fig0020){ref-type="fig"}G). Morphologically, positive cells showed histiocytic morphology with abundant diffusely to slightly granular positive cytoplasm and peripheral nuclei ([Fig. 4](#fig0020){ref-type="fig"}H). In contrast to the sparse distribution in camelids, CD68, a lysosomal/plasma membrane shuttling protein localized to endo- and lysosomes, is known to be a pan-macrophage marker in humans ([@bib0105], [@bib0220]). Further studies will be needed to evaluate how the CD68-positive camelid population differs from the rather broader positive population in other species, and whether the observed differences are attributed to the species or technical variations.

Antibodies against CD205 and CD208 antigen were applied for the detection of DCs, as previously reported in cattle ([@bib0180]), sheep ([@bib0005]) and humans ([@bib0275], [@bib0090]). Only CD208 (synonym dendritic cell lysosomal-associated membrane protein \[DC-LAMP\]) revealed specific immunoreaction on few histiocytic cells in camelid tissue ([Fig. 5](#fig0025){ref-type="fig"} A--D). Positive cells were rarely present in the splenic red pulp and PALS ([Fig. 5](#fig0025){ref-type="fig"}A) as well as in LN, DALT, and the DLT of lymph nodes ([Fig. 5](#fig0025){ref-type="fig"}B), while CD208 was neither detected in the medulla nor the cortex of thymus ([Fig. 5](#fig0025){ref-type="fig"}C). Morphologically, positive camelid cells were characterized by an intense coarsely granular immunosignal within the cytoplasm, probably indicating labelling of lysosomes ([Fig. 5](#fig0025){ref-type="fig"}D). CD208 is reported to be expressed by mature and activated DCs, but not on unactivated DCs of humans ([@bib0275]). The relative paucity of positive cells on camelid tissue indicates that CD208 might similarly detect only mature camelid DCs.Fig. 5Representative immunohistochemical reaction for the detection of dendritic cells in the spleen, lymph node, and thymus of a Bactrian camel (A-D: CD208). Avidin-biotin-peroxidase complex method with 3,3′-diaminobenzidine as chromogen. (A) CD208; spleen. Immunpositive cells are noted scattered throughout the splenic red pulp (RP) and rarely within the periarteriolar lymphoid sheath (PALS). Scale bar = 100 μm. (B) CD208; lymph node. Similar to the spleen, few individualized CD208 positive cells are seen in all lymph node compartments (DLT = diffuse lymphoid tissue; DALT = dense anodular lymphoid tissue). Scale bar = 100 μm. (C) CD208; thymus. Note absent immunopositivity. Scale bar = Scale bar = 100 μm. (D) CD208; lymph node. Higher magnification of the inset in (B). CD208 immunopositive cells are characterized by peripherally located nuclei, moderate to high amounts of cytoplasm, and an intense coarsely granular immunosignal within the cytoplasm (arrows). The granular signal indicates that the signal is associated with lysosomes of dendritic cells (CD208 = synonym for dendritic cell lysosomal-associated membrane protein \[DC-LAMP\]). Scale bar = 20 μm.Fig. 5

4. Conclusion {#sec0060}
=============

Summarized, 9 out of 14 tested commercially available antibodies showed immunoreactivity on distinct cell types in FFPE lymphoid tissue of different camelid species. The presented antibody panel appears to be suitable for the detection of the most important subpopulations of immune cells, including T and B cells, macrophages and DCs in FFPE tissue of camelids. Doubtlessly, the present results, especially those obtained from thymus, need to be interpreted on the basis of relatively small animal numbers. Nevertheless, the established markers will provide a solid basis for the investigation of naturally occurring and experimental diseases of camelids with a special emphasis on emerging spill-over infections such as Middle East respiratory syndrome.
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[^1]: CD, cluster of differentiation; Pax-5, paired box protein 5; MUM1, multiple myeloma oncogene 1; Foxp3, forkhead box P3, HLA, human leucocyte antigen; Iba-1, ionized calcium-binding adapter molecule 1; pc, polyclonal; mc, monoclonal; \#, antigen retrieval was performed with boiling citrate buffer, pronase, and omission of pretreatment; GAR, goat anti-rabbit Immunoglobulin G (IgG); GAM, goat anti-mouse IgG; RAR, rabbit anti-rat IgG; +, positive; −, negative; (+) the antibody displayed a distinct immunoreaction on certain cells, but there was considerable background staining, false nuclear reactions, and the number of labeled cells was significantly lower than in the positive control of canine tissue.

[^2]: Averages (upper rows) and standard deviations (lower rows) of immunopositive cells were calculated from score values (0, no positive staining cells; 1, \< 10%; 2, 10--50%; 3, 51--90%; 4, \> 90% of immunolabeled cells) for different compartments of spleen. Thymus tissue was only available from a low number of animals and thus not included in the table. llamas; A, alpacas; D, dromedaries; C, Bactrian camels; PALS, periarteriolar lymphoid sheaths; CD, cluster of differentiation; HLA, human leucocyte antigen; Iba-1, ionized calcium-binding adapter molecule 1; m/h antigen, myeloid/histiocyte antigen.

[^3]: Averages (upper rows) and standard deviations (lower rows) of immunopositive cells were calculated from score values (0, no positive staining cells; 1, \<10%; 2, 10--50%; 3, 51--90%; 4, \>90% of immunolabeled cells) for different compartments of pulmonary (white values) and mesenteric lymph nodes (grey values). Thymus tissue was only available from a low number of animals and thus not included in the table. llamas; A, alpacas; D, dromedaries; C, Bactrian camels; CD, cluster of differentiation; HLA, human leucocyte antigen; Iba-1, ionized calcium-binding adapter molecule 1; m/h antigen, myeloid/histiocyte antigen.
